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Abstract
Background/Aim. Concerning the growth of ovarian car-
cinoma incidence and bad prognosis for malignant forms,
early and precise diagnostics is gaining in importance as a
condition for precise and appropriate therapy for ovarian
tumor masses. The aim of this study was to analyze pre- and
postoperative findings of patients with adnexal masses in
order to identify factors which could predict the nature and
stage of the tumor prior to surgery. Methods. All patients
with adnexal masses who were treated in a 6-month period
in the Institute of Obstetrics and Gynecology, Clinical
Center of Serbia, (IOG, CCS), Belgrade, had their epidemi-
ologic and gynecologic anamnesis and standard laboratory
analyses taken prior to surgery. Also, clinical and ultrasono-
graphic check up of pelvic organs was performed, as well as
calculation of body mass index (BMI) and risk of
malignancy index (RMI). After surgery we analyzed histo-
pathological (HP) findings of tumors as a mean of final dia-
gnosis and staging. For statistical analysis, we used SPSS 15
program.  Results. Throughout a 6-month period, we
examined 81 patients with adnexal masses treated in the
IOG CCS. HP findings showed that there were significantly
more benign (n = 51) than malignant (n = 30) tumors in all
the patients (χ2 = 5.512). The patients with malignant HP
findings were significantly older than those with benign
adnexal masses (t = 3.362;  p = 0.001).  Significantly  more
patients with malignant HP findings were in menopause
(p = 0.034). BMI values were highly significantly higher in
the patients with malignant adnexal tumors (t = 3.421;
p = 0.001). There was a statistically significant positive cor-
relation between HP categories (benign, malignant) and
RMI categories (low, intermediate and high risk) of all the
patients (high risk, more malignant HP) (Roxy = 0.428;
df = 78;  p = 0.000).  Conclusion.  Patients in menopause,
especially older ones, with high BMI and RMI should
immediately be referred to a tertiary level institution, where
appropriate surgery could be performed.
Key words:
ovarian neoplasms; risk assessment; ultrasonography;
body mass index; menopause; histological techniques.
 Apstrakt
Uvod/Cilj. S obzirom na porast incidencije tumora jajnika
u populaciji i lošu prognozu malignih promena, rana i preci-
zna dijagnostika postaje sve značajnija kao preduslov za
pravilnu i efikasnu terapiju tumorskih promena jajnika. Cilj
studije bio je analiza pre- i postoperativnih nalaza kod bole-
snica sa adneksalnim masama radi identifikacije faktora koji
bi preoperativno mogli ukazati na prirodu i stadijum bolesti.
Metode. Svim bolesnicama sa adneksalnim tumorima leče-
nim u Institutu za ginekologiju i akušerstvo Kliničkog centra
Srbije (IGA, KCS), Beograd, tokom 6-mesečnog perioda
uzete su preoperativno epidemiološka i ginekološka anam-
neza, urađene su standardne laboratorijske analize, klinički i
ultrazvučni pregled organa male karlice, određen indeks te-
lesne mase (BMI) i izračunat indeks rizika od malignosti
(RMI). Posle operativnog zahvata analizirani su histopatolo-
ški (HP) nalazi odstranjenih adneksalnih tumora u cilju ko-
načne dijagnostike i određivanja stadijuma bolesti. Za statis-
tičku analizu korišćen je statistički program SPSS 15. Re-
zultati. U toku 6-mesečnog ispitivanja u IGA KCS lečila se
81 bolesnica sa tumorom adneksa. Histopatološkim nala-
zom značajno češće je registrovan benigni (n = 51), nego
maligni (n = 30) tumefakt kod svih ispitanica (Χ2 = 5,512).
Ispitanice sa malignim HP nalazom bile su visokoznačajno
starije od ispitanica sa benignim promenama adneksa
(t = 3,362; p = 0,001). Značajno više bilo je ispitanica u me-Strana 862 VOJNOSANITETSKI PREGLED Volumen 68, Broj 10
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nopauzi sa malignim HP nalazom (p = 0,034).  Vrednosti
BMI bile su visokoznačajno više kod ispitanica sa malignim
tumorom (t = 3,421; p = 0,001). Postoji statistički značajna
pozitivna povezanost kategorija HP nalaza (maligni, benig-
ni) i kategorija rizika (nizak, srednji i visok) svih ispitanica
(veći rizik, maligniji HP) (Roχy = 0,428; df = 78; p = 0,000).
Zaključak. Bolesnice u menopauzi, naročito starije, sa vi-
sokim BMI i RMI trebalo bi odmah uputiti u ustanovu ter-
cijarnog nivoa, u kojoj se može sprovesti operativni zahvat
neophodne opsežnosti.
Ključne reči:
jajnik, neoplazme; rizik, procena; ultrasonografija,
telesna masa, indeks; menopauza; histološke tehnike.
Introduction
Ovaries are highly capable of producing both benign
and malignant tumors throughout a woman’s life. Due to the
complex ovarian structure, histopathological (HP) findings
of adnexal tumors can be quite different 
1. Although ovarian
cancer is sixth in frequency among all malignant tumors, the
mortality it takes has the leading place 
2, 3. Numerous factors
influence the development and growth of adnexal tumors
such as heritage, hormones, alimentation, surrounding, etc 
4,
5. Assuming that etiology and pathogenesis is complex and
still not completely clearified, ovarian cancer presents a great
diagnostic challenge. Early, correct and detailed diagnostics,
adequate preoperative stage evaluation and preparation as
well as up-to-date therapy are obligatory for adequate treat-
ment of ovarian carcinoma 
2.
The aim of the study was to analyze pre- and postop-
erative findings in patients with adnexal masses in order to
identify factors which could preoperatively imply on the na-
ture and stage of the tumor and in that way refer high-risk
patients to a tertiary institution where appropriate (radical)
operative procedures could be done.
Methods
The study included all consecutive patients with ad-
nexal masses hospitalized at the Institute of Gynecology and
Obstetrics, Clinical Center of Serbia during the first six
months of 2010. Preoperatively, from all patients, basic epi-
demiological data (age, educational level, occupation, and
residency) and gynecological anamnesis (menarche age, par-
ity, last menstrual cycle, and symptoms) were taken, as well
as the standard laboratory analysis (blood analysis, sedi-
mentation, tumor marker levels). Furthermore, clinical and
ultrasonographic examinations of pelvic organs (tumor di-
mensions, multilocular or bilateral tumor, solid/cystic com-
ponents/ parts, metastasis and free fluid presence) were per-
formed and body mass index (BMI) was assessed. Finally,
risk of malignancy index (RMI) for all the patients was cal-
culated, using the formula: RMI  = U   M   Ca125. In the
formula U represents the ultrasonographic index. Multilocu-
lar and bilateral tumors, the presence of solid parts in tumor,
metastasis and ascites are marked with one point each. The
sum of these points, are scored so that in the formula U 0 = 0
points, U 1 = 1 points, U 2 - 5 = 3 points. In the formula M
represents menopausal status (1 for premenopausal and 3 for
postmenopausal women). Values of Ca125 are calculated di-
rectly to the equation. The patients were divided into three
groups according to the RMI values (low risk < 25, interme-
diate risk 25–200, high risk > 200). After surgery, the HP
findings of excised tumors were analyzed in order to make
the final diagnosis and the stage of the disease. For statistical
analysis of the achieved data we used: mean value, meas-
urements of variability (confidence interval and standard de-
viation), Kolmogorov-Smirnov Z test, Friedman’s parametric
ANOVA, Kruskal – Walis nonparametric ANOVA, Rank-
sum test, χ
2 test, Fisher’s test and Spearman’s nonparametric
rank correlation. For data analysis SPSS 15 computer pro-
gram was used.
Results
During a 6-month investigatian period at the Institute of
Gynecology and Obstetrics there were 81 patients with ad-
nexal tumors. Out of that number 51 (62.96%) patients were
still in their reproductive period, while 30 (37.04%) women
were already in menopause. The age of the women with ad-
nexal masses was in the range of 66 years (min  =  16,
max = 82), with an average of 44.138 (SD = 14.496) years.
The values of the patients’ age correspond with the model of
normal data division. The confidence interval of the age in
which the investigated women had menarche was 7 years
(min  =  10, max  =  17) and the average age was 13.188
(SD  =  1.543) years. These values were also normally di-
vided. BMI values of the patients range from minimal 19.0
kg/m
2 to maximal 37.1 kg/m
2 ( i = 18.1),  while  the  mean
value was 24.805 (SD  =  4.208) kg/m
2. The values of the
women’s BMI act according to the normal distribution model
and age are presented in Figure 1. Minimal number of births,
miscarriages and abortions was 0. The women maximally
had 4 births, 3 miscarriages and 10 abortions. Tumor dimen-
sions were in an interval from 1 to 20 cm (i = 19), with a
mean value of 7.278 (SD = 3.787) cm. Sedimentation values
varied from normal – referral to maximal 129 and the mean
value was 21.675 (SD  =  24.188). Ca125 values vary from
minimal 2.4 do maximal 963.6 U/mL (i = 960.6), although,
one extreme value Ca125 of 13,623.0 had to be excluded so
that the statistical analysis could be more correct. The mean
value was 120.343 (SD  =  195.895) U/mL, median 30.700
U/mL, and mode 10.000 U/mL. The calculated RMI values
range from 0.0 to 6,912 with the mean value of 407.776
(SD  =  1,105.623), median of 37.400 and mode of 0.000.
From this analysis one extreme RMI value of 122,607.00
was excluded.
Frequency in all the patients with adnexal masses does
not differ significantly (p > 0.05) concerning the categories
of these characteristics: educational level (χ
2 = 0.312),  bio-
chemical analysis (χ
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symptom (χ
2 = 2.112). Frequency in all the patients with ad-
nexal masses significantly differs (p < 0.05) concerning the
categories of these characteristics: HP findings, menopausal
status, RMI, symptoms type and highly significantly
(p < 0.01) concerning the categories of these characteristics:
residency, blood analysis, tumor dimensions and the pres-
ence of the symptoms. Frequencies in patients regarding the
investigated parameters are shown in Table 1.
In the HP findings there were significantly more often
registered benign (n = 51, 62.96%) than malignant (n = 30,
37.04%) tumors in all the investigated women (χ
2
 = 5.512).
Adnexal masses were significantly more rare in the meno-
pausal than in the younger women (χ
2
 = 5.512). Significantly
less frequent were the patients with high RMI and more fre-
quent the patients with low RMI (χ
2 = 7.600, df = 2). There
were significantly less women with vaginal bleeding
(χ
2 = 7.295, df = 2) as well as with a symptom combination –
pain and other symptoms (χ
2 = 8.001, df = 2). Out of all the
women with adnexal masses highly significantly more
women (χ
2
 = 26.406) had referral blood analysis. Highly sig-
nificantly more (χ
2 = 13.075,  df = 2)  tumors  had  diameter
ranging from 5.1 cm to 10 cm, and less diameter bigger than
10 cm. A significant difference (χ
2 = 64.204, df = 6) regard-
ing the symptom presence categories is due to the high fre-
quency in patients without symptoms and a low frequency in
patients with vaginal bleeding and a symptoms combination.
Table 1
Frequencies in patients regarding the investigated parameters
Frequencies in number (%) of patients Parameter Parameter categories Total Malignant Benign
Primary and secondary 44 (54.32) 23 (76.67) 21 (41.18) Educational level High school and university 37 (45.68) 7 (23.33) 30 (58.82)
Belgrade 61 (75.31) 19 (63.33) 42 (82.35) Residency
Other 20 (24.69) 11 (36.67) 9 (17.65)
None 33 (40.75) 11 (36.67) 22 (43.14)
Pain 16 (19.75) 4 (13.33) 12 (23.53)
Vaginal bleeding 4 (4.94) 2 (6.67) 2 (3.92)
Waist diameter enlargement and
appetite loss 14 (17.28) 7 (23.33) 7 (13.73)
Pain and vaginal bleeding 3 (3.7) 2 (6.67) 1 (1.96)
Pain, waist diameter enlargement and
appetite loss 9 (11.11) 3 (10) 6 (11.77)
Symptoms
Pain, vaginal bleeding, waist diameter
enlargement and appetite loss 2 (2.47) 1 (3.33) 1 (1.96)
≤ 5 cm 41 (50.62) 7 (23.33) 34 (66.67)
5.1–10 25 (30.86) 11 (36.67) 14 (27.45) Tumor diameter
≥ 10 cm 15 (18.52) 12 (40) 3 (5.88)
Correct 73 (90.12) 25 (83.33) 48 (94.12) Blood analyses
Incorrect 8 (9.88) 5 (16.67) 3 (5.88)
Correct 47 (58.02) 17 (56.56) 30 (58.82) Biochemical analyses
Incorrect 34 (41.98) 13 (43.33) 21 (41.18)
Low 36 (44.44) 5 (16.67) 31 (60.79)
Medium 29 (35.8) 12 (40) 17 (33.33)
Risk regarding
RMI values
High 16 (19.75) 13 (43.33) 3 (5.88)
RMI – Risk of Malignancy Index
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Fig. 1 – Minimal (min), maximal (max) and mean values of investigated parameters
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There were highly significantly more (χ
2
 = 8,511)  patients
with only one (any one) symptom than those with a symp-
toms combination. Highly significantly more patients
(χ
2
 = 21,012) lived in Belgrade than anywhere else in Serbia.
When the preoperatively obtained data were compared
with the HP findings of excised tumors the following results
were gained. Frequencies in patients regarding the categories
of both educational level (primary, secondary or high school
and university) and HP findings (benign, malignant) did not
differ significantly (χ
2 = 0.252; df = 1; p = 0.616). Frequen-
cies in patients when assessed both categories of patient’s
residency and HP findings did not differ significantly
(χ
2 = 3.000; df = 1; p = 0.083). Also, there were no signifi-
cant differences (p > 0.05) regarding both categories of HP
findings and examined factors: age at which patients had
menarche (t = 1.054;  p  =  0.295), number of births
(W = 1677.000;  Z = 0.954;  p = 0.340),  number  of  miscar-
riages (W = 1709.000;  Z = 0.823;  p = 0.411)  and  abortions
(W = 872.500; Z = 0.048; p = 0.961). Frequencies in patients
when examined categories of biochemical analyses (correct,
incorrect) together with categories of HP findings did not
differ significantly (χ
2 = 0.010; df = 1; p = 0.920; p > 0.05).
Frequencies in patients regarding the categories of blood
analyses (correct, incorrect) and HP findings did not differ
significantly (P = 0.125; p > 0.05). Sedimentation values of
women with adnexal masses do not differ significantly re-
garding the factor of categories of HP findings (benign, ma-
lignant) (W = 1599.500;  Z = 1.824;  p = 0.068).  Tumor  di-
ameters did not significantly differ regarding the categories
of HP findings (W = 1737.500;  χ = 0.174;  p = 0.862).  The
values of tumor marker Ca125 statistically significantly dif-
fered regarding the categories of HP findings (benign, ma-
lignant) (p < 0.05).
Frequencies in patients with adnexal masses assessed
regarding both the symptom presence (present, not present)
and HP categories (benign, malignant) significantly differed
(χ
2 = 1.029;  df = 1;  p  =  0.310). However, a more detailed
analysis showes that there are no differences neither in HP
findings and symptom types (pain, vaginal bleeding, other)
(P1, 2 = 0.397; P1, 3 = 0.311; P2, 3 = 0.440), presence of one or
more than one symptom (P = 0.260),  nor  in  symptom
combinations (pain and vaginal bleeding; pain and other
symptoms; pain, vaginal bleeding and other symptoms)
(P1, 2 = 0.061; P1, 3 = 0.250; P2, 3 = 0.778).
The age of  the  patients with adnexal masses signifi-
cantly differed regarding the factor of categories of HP
findings (t = 3.362; p = 0.001). The patients with malignant
HP findings were highly significantly older than patients
with benign adnexal masses. Frequencies in women when
categories of menopausal status (pre or post menopauses)
and HP findings were evaluated together, were significantly
different (p  =  0.034). There were significantly more post-
menopausal women with malignant HP findings in compari-
son with premenopausal patients with benign adnexal
masses.
BMI values of the patients with adnexal masses signifi-
cantly differed concerning the factor of the HP findings cate-
gories (t = 3.421; p = 0.001). BMI values were significantly
higher in the patients with malignant HP findings than in
those with benign adnexal tumors.
Frequencies in patients with adnexal masses when cate-
gories of HP findings (benign, malignant) and categories of
the risk for malignant adnexal tumor (low, intermediate,
high), achieved by calculating RMI, were evaluated together,
significantly differed (χ
2 = 18.624;  df = 2;  p = 0.000).  This
difference was due to the rare malignant HP findings in the
patients with low and intermediate RMI and benign HP
findings in patients with high RMI (χ
2
1, 2 = 1.379; df = 1; P1,
2 = 0.118; P1, 3 = 0.00004; P2, 3 = 0.002).
Correlation of categories of HP findings (benign, ma-
lignant) and categories of the risk (low, intermediate, high)
of all the patients was positive (higher-risk, malignant HP)
and of highly significant strength (Roxy = 0.428;  df = 78;
p = 0.000).
Discussion
According to the literature one of the factors which
could predict the stage and survival of patients as well as the
tumors recurrence is their age. Older patients are under
higher risk for worse outcome 
2, 5. These data correspond
with the results of our study which has proven that patients
with malignant tumors are significantly older than those who
had benign masses.
Authors emphasize the significance of environmental
factors for the development of malignant adnexal masses 
4.
Regarding the results of our study, which evaluated educa-
tional level, occupation and residency, there were no statisti-
cal differences between patients with benign and malignant
tumors. Furthermore, there were no correlations at all of
these factors with tumor development. There were more pa-
tients from Belgrade only, but this could be explained by the
fact that Belgrade was the place where this study was con-
ducted.
Pregnancy is considered to have protective effect on the
development of ovarian cancer 
2, 6. Contrary to what might be
expected, in the examined population, the number of preg-
nancies (births, miscarriages and abortions) did not show a
significantly different distribution between benign and ma-
lignant adnexal masses. Therefore, pregnancy cannot be con-
sidered a clear predictive factor that could help in preopera-
tive evaluation of adnexal masses.
Symptoms linked to ovarian carcinoma usually are pel-
vic and abdominal pain, waist diameter enlargement, appetite
loss, nausea and frequent urination over a prolonged period 
7.
Although these symptoms, in some studies, have the inci-
dence of even 90% in older women, in the population we in-
vestigated, most women from both groups of patients with
benign and malignant tumors, had no symptoms at all. Be-
sides, neither one of the symptoms nor their combination,
have significantly proven to be a clear predictive factor for
malignant nature of the adnexal tumor. When the achieved
results are taken into consideration, it can be concluded that
even the asymptomatic patients demand detailed diagnostics.
The very fact that a woman is in menopause presents a
risk that the adnexal mass is of malignant nature 
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confirmed by the results of our study. On the other hand, pa-
tients in the reproductive period more often have benignt ad-
nexal masses.
High BMI values have been connected to the breast and
endometrial carcinoma so far. Contemporary investigations
show that obesity can be a risk factor also for ovarian carci-
noma. It is considered that in the etiology of all of the above-
mentioned carcinomas hormonal mechanisms have the lead-
ing role, but they should still be examined more thoroughly 
6,
9. The results of our study correspond with the literature data,
that there is a statistically highly significant correlation be-
tween higher values of BMI and malignant HP findings of
adnexal masses.
For differentiation of benign and malignant adnexal
masses the method of RMI calculation is usually done 
10, 11.
Numerous studies have shown that RMI has high sensitiv-
ity, specificity and predictive value for adnexal tumor
evaluation 
12–14. RMI calculation is a swift and easy method
that does not need special technical equipment and there-
fore it is considered a method of choice for preoperative
screening of adnexal masses 
15, 16. Moreover, the risk which
is assessed by this method is more reliable than to evaluate
separately menopausal status, ultrasonographic findings
and Ca125 level 
8, 17, 18. The results obtained in this investi-
gation point out a significant diagnostic contributions that
RMI calculation offers to a preoperative evaluation of ad-
nexal masses.
Although contrary to usual findings 
17, 18 and our ex-
pectations, no other investigated parameter (blood analyses,
sedimentation, biochemical analyses) in our population had a
statistical significance as a risk factor that could imply to the
malignant nature of the tumor, so, in a preoperative tumor
evaluation and in the process of deciding on the radicalism of
the procedure, they cannot be considered reliable.
Conclusions
The average age of the women with adnexal masses
was 44.138 years. Adnexal masses are more frequent in the
younger women. On the other hand, the patients with malig-
nant HP findings are highly significantly older and more of-
ten postmenopausal, than patients with benign adnexal
masses. Regarding the fact that patients are usually asymp-
tomatic, regular gynecological check-ups are needed in order
to diagnose pathological changes in early stages. The time of
the first menstrual cycle, parity, tumor diameter, blood and
biochemical analyses, as well as symptomatology are not
good indicators of the nature (benign, malignant) and the
clinical stage of adnexal masses. Levels of Ca125 are high in
patients with malignant adnexal tumors. BMI values corre-
spond to the risk level (lower BMI is in benign and higher in
malignant tumors), so in a preoperative evaluation of adnexal
masses a patient’s BMI should be taken into consideration.
HP findings and the risk categories (RMI low, intermediate,
high) are in a positive correlation. Therefore, it can be con-
cluded that RMI presents a significant factor that could pre-
operatively imply to the diagnosis and the stage of adnexal
masses and consequently it is recommended that RMI is al-
ways calculated. Patients in menopause, especially older,
with high BMI and RMI values should be immediately re-
ferred to a tertiary institution where appropriate extensive
operative procedure could be performed.
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